Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ESMO 2020
Pharma
Regeneron, Sanofi won't dethrone Merck in lung cancer: analysts
Can Regeneron's and Sanofi's PD-1 blocker Libtayo unseat Merck's Keytruda in NSCLC? It's unlikely, concluded analysts after parsing data from ESMO.
Arlene Weintraub
Sep 24, 2020 10:41am
How will new BMS Opdivo kidney cancer combo do against Keytruda?
Sep 22, 2020 11:47am
BMS' Opdivo fends off hard-to-treat esophageal, gastric cancers
Sep 21, 2020 12:30pm
Merck's Keytruda pushes for 2nd esophageal cancer nod
Sep 21, 2020 12:30pm
Roche pins Tecentriq ovarian cancer hopes on final survival data
Sep 21, 2020 10:20am
ESMO: Regeneron and Sanofi's Libtayo guns for first-line NSCLC
Sep 21, 2020 8:25am
